Nizatidine Articles
Dr Reddy's 3rd-qtr net profit falls 11%
9 February 2004
First approvals for generic Axid in USA
15 July 2002
Update: Alkermes to acquire Reliant in $934M deal
1 April 2002
Alkermes to acquire Reliant in $934M deal
25 March 2002
Axid cuts weight gain seen with Zyprexa
8 May 2001
Lilly sells Axid rights to Norgine in European markets
22 November 2000
American Home Pharma Sales Up 7% For 2nd Qtr
22 July 1998
Canadian High Court Slams Drug Laws
21 July 1998
Pharmaceutical Companies Face Up To The Future
15 June 1998
US Quarterly Financial Results Round-Up
23 April 1998
FDA Clears GW's Effervescent Zantac
5 March 1998
Greece To Slim Official Drug List
4 February 1998
UK Planning Product Status Switches
21 January 1998
Australia Excludes SSRIs From Final TGP Scheme
17 December 1997
French Drug Firms Censured Over Promotions
12 August 1997
Generic Ranitidine Finally Reaches US Market
5 August 1997
H2 Blockers' US Sales Boom Set To Slow?
21 October 1996
The Role Of Managed Care In Rx-To-OTC Switches
21 October 1996
AHP Receives Approval For OTC Advil
15 July 1996
Tactical Diversity In The Evolving US Health Market
17 June 1996
Mixed Earnings But Strong Sales For US Companies
12 February 1996
Whitehall-Robins: nizatidine news
9 October 1995
Weaker US Dollar And Volume Growth Lift 1st Qtr
24 April 1995
Eli Lilly Publishes Letter
27 February 1995
Good Year for Eli Lilly Driven By Prozac
20 February 1995
Glaxo Rumored To Be Eying Eli Lilly
22 August 1994
Benefits From PBM/MPC Acquisitions Assessed
15 August 1994
FDA Warns Lilly Over Axid Claims
1 August 1994
LILLY TO MARKET GENERIC TAGAMET
25 April 1994
RESTRUCTURING CHARGES DEPRESS LILLY AND E KODAK
14 February 1994
UK PRODUCT NEWS IN BRIEF
7 February 1994
US 3rd QTR RESULTS MIXED AS DRUG IND CUTS BACK
25 October 1993
ULCER DRUG MARKET DECLINE FORECAST
4 October 1993
ADVANCES BY US DRUG COMPANIES IN 2nd QTR
26 July 1993
OTC GASTROINTESTINALS IN THE USA
24 May 1993
STUDY ON H2 ANTAGONISTS AND ALCOHOL
12 April 1993
US 4th QTR SHOWS NOT ALL COMPANIES STRONG
15 February 1993
GLAXO TO FILE FOR OTC ZANTAC IN 1994?
1 February 1993
GLAXO AND LILLY'S ULCER DRUGS OFF MEDI-CAL
18 January 1993
US RESULTS 3RD QTR
2 November 1992
STUDY SUPPORTS ULCER/H PYLORI HYPOTHESIS
11 May 1992
Showing 1-43 of 43 articles
- 1
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
